AR054707A1 - DERIVATIVES OF OCTAHIDROPIRROLO 3,4-C PIRROL, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT - Google Patents

DERIVATIVES OF OCTAHIDROPIRROLO 3,4-C PIRROL, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Info

Publication number
AR054707A1
AR054707A1 ARP050104891A ARP050104891A AR054707A1 AR 054707 A1 AR054707 A1 AR 054707A1 AR P050104891 A ARP050104891 A AR P050104891A AR P050104891 A ARP050104891 A AR P050104891A AR 054707 A1 AR054707 A1 AR 054707A1
Authority
AR
Argentina
Prior art keywords
compound
manufacture
preparation
octahidropirrolo
pirrol
Prior art date
Application number
ARP050104891A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35985757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR054707(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP04106044A external-priority patent/EP1671972A1/en
Application filed by Pfizer filed Critical Pfizer
Publication of AR054707A1 publication Critical patent/AR054707A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Procedimientos para la preparacion del compuesto, composiciones farmacéuticas que los contienen y uso del compuesto para la fabricacion de un medicamento. Estos compuestos son apropiados para el tratamiento de enfermedades inflamatorias como artritis reumatoide, asma, psoriasis y otras. Reivindicacion 1: Un compuesto de formula (1) o sales y solvatos farmacéuticamente aceptables del mismo, en la que: R1 es H o alquilo C1-4 opcionalmente sustituido con un hidroxi, X es N o C-R9 donde R9 es H o metilo; Y es O o NH; R6 es H o metilo; y R2, R3, R4 y R5 se seleccionan independientemente entre H, halo, ciano, alquilo C1-4, alcoxi C1-4, trifluorometilo, trifluorometoxi, hidroxi,. (CH2)n-C(O)O-R7, (CH2)n-O-(CH2) m-R8 y (CH2)n-R8, donde n y m son ambos independientemente 0 o 1; R7 es H o alquilo C1-4 y R8 es fenilo.Procedures for the preparation of the compound, pharmaceutical compositions containing them and use of the compound for the manufacture of a medicament. These compounds are suitable for the treatment of inflammatory diseases such as rheumatoid arthritis, asthma, psoriasis and others. Claim 1: A compound of formula (1) or pharmaceutically acceptable salts and solvates thereof, wherein: R1 is H or C1-4 alkyl optionally substituted with a hydroxy, X is N or C-R9 where R9 is H or methyl ; Y is O or NH; R6 is H or methyl; and R2, R3, R4 and R5 are independently selected from H, halo, cyano, C1-4 alkyl, C1-4 alkoxy, trifluoromethyl, trifluoromethoxy, hydroxy ,. (CH2) n-C (O) O-R7, (CH2) n-O- (CH2) m-R8 and (CH2) n-R8, where n and m are both independently 0 or 1; R7 is H or C1-4 alkyl and R8 is phenyl.

ARP050104891A 2004-11-24 2005-11-22 DERIVATIVES OF OCTAHIDROPIRROLO 3,4-C PIRROL, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AR054707A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106044A EP1671972A1 (en) 2004-11-24 2004-11-24 Octahydropyrrolo[3,4-c]pyrrole derivatives
EP05100474 2005-01-26

Publications (1)

Publication Number Publication Date
AR054707A1 true AR054707A1 (en) 2007-07-11

Family

ID=35985757

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104891A AR054707A1 (en) 2004-11-24 2005-11-22 DERIVATIVES OF OCTAHIDROPIRROLO 3,4-C PIRROL, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Country Status (12)

Country Link
EP (1) EP1846409A1 (en)
JP (1) JP2008520644A (en)
AR (1) AR054707A1 (en)
CA (1) CA2587141A1 (en)
GT (1) GT200500340A (en)
NL (1) NL1030503C2 (en)
PA (1) PA8653801A1 (en)
PE (1) PE20061055A1 (en)
SV (1) SV2007002315A (en)
TW (1) TW200626600A (en)
UY (1) UY29221A1 (en)
WO (1) WO2006056848A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5650404B2 (en) 2006-12-28 2015-01-07 ライジェル ファーマシューティカルズ, インコーポレイテッド N-substituted heterocycloalkyloxybenzamide compounds and methods of use thereof
EP2201982A1 (en) 2008-12-24 2010-06-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Histamine H4 receptor antagonists for the treatment of vestibular disorders
US20120277238A1 (en) * 2009-07-31 2012-11-01 Shionogi & Co., Ltd Pharmaceutical composition containing fused hetero-ring derivative
PL2491038T3 (en) 2009-10-23 2016-10-31 Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
JP5847087B2 (en) 2009-10-23 2016-01-20 ヤンセン ファーマシューティカ エヌ.ベー. Fused heterocyclic compounds as orexin receptor modulators
WO2011050202A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Fused heterocyclic compounds as orexin receptor modulators
WO2012145581A1 (en) 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
DK2858647T3 (en) 2012-06-08 2018-08-20 Sensorion H4 RECEPTOR INHIBITORS FOR TINNITUS TREATMENT
HUE058759T2 (en) 2016-03-10 2022-09-28 Janssen Pharmaceutica Nv Methods of treating depression using orexin-2 receptor antagonists
WO2019152883A1 (en) * 2018-02-02 2019-08-08 Padforward Llc Inhibitors of protein arginine deiminases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2620341A (en) * 1949-03-24 1952-12-02 Burroughs Wellcome Co N,n-dialkyl-quinoline-4-carboxamidines
PT828741E (en) * 1995-05-11 2002-02-28 Upjohn Co OXAZOLIDINONES OF SPIROCYCLIC AND BICYCLE DIAZINYL AND CARBAZINYL
GB9902453D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
CA2440803A1 (en) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
US6803362B2 (en) * 2001-03-09 2004-10-12 Ortho-Mcneil Pharmaceutical Inc. Heterocyclic compounds
WO2004021999A2 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma
AU2003272285A1 (en) * 2002-09-06 2004-03-29 Janssen Pharmaceutica, N.V. Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
KR20050033662A (en) * 2002-09-06 2005-04-12 얀센 파마슈티카 엔.브이. Heterocyclic compounds

Also Published As

Publication number Publication date
JP2008520644A (en) 2008-06-19
SV2007002315A (en) 2007-02-16
NL1030503C2 (en) 2006-11-28
UY29221A1 (en) 2006-06-30
CA2587141A1 (en) 2006-06-01
PE20061055A1 (en) 2006-11-09
TW200626600A (en) 2006-08-01
WO2006056848A1 (en) 2006-06-01
NL1030503A1 (en) 2006-05-29
GT200500340A (en) 2006-07-13
EP1846409A1 (en) 2007-10-24
PA8653801A1 (en) 2006-06-02

Similar Documents

Publication Publication Date Title
AR054707A1 (en) DERIVATIVES OF OCTAHIDROPIRROLO 3,4-C PIRROL, A PROCEDURE FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
UA74391C2 (en) Aryl- or heteroarylcondensed imidazoles as anti-inflammatory and analgesic agents
PA8547901A1 (en) 4-PIPERACINYLINDOL DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
AR077267A1 (en) SELECTED INHIBITING NITROGEN DERIVATIVES OF PI3K, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF INFLAMMATORY AND / OR AUTOIMMUNE DISEASES.
AR037517A1 (en) DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE
AR046297A1 (en) DPP INHIBITORS - IV METHODS TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AS ACTIVE AGENTS
EA200500018A1 (en) BENZONE-CONDENSED HETEROARILAMIDE TYENOPIRIDIN DERIVATIVES USED AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, INCLUDING THEM, AND THEIR APPLICATION
AR041566A1 (en) INDOL DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES
CL2004000917A1 (en) COMPOUNDS DERIVED FROM TIAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE FOR THE TREATMENT OF DISEASES MEDIATED BY DOSFATIDILNOSITOL 3-KINASE SUCH AS RESPIRATORY DISEASES, ALLERGIES, Rheumatoid Arthritis, OSTEOA
PA8580301A1 (en) NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS
ECSP066383A (en) DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES
PA8582801A1 (en) NEW SPIROTRICYCLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE
ATE440834T1 (en) SUBSTITUTED ARYLAMIN DERIVATIVES AND METHODS OF USE
UY29234A1 (en) ADAMANTAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, BOTH PREPARATION PROCEDURES AND APPLICATIONS.
UY29393A1 (en) NEW DERIVATIVES OF AMIDAS, ACCEPTABLE PHARMACEUTICAL SALTS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS.
AR029821A1 (en) DECAHIDRO-ISOQUINOLINAS, A PROCESS FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AR045155A1 (en) DERIVATIVES OF 6-INDOLILSULFONAMIDS, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS
NO20025640D0 (en) Substituted 1-aminoalkyl lactams and their use as muscarinic receptor antagonists
AR074353A1 (en) NAFTALEN-2-IL-ACETIC ACIDS SUBSTITUTED, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND USE OF THE SAME IN THE TREATMENT OF ALLERGIC DISEASES, SUCH AS RHINITIS, ASTHMA AND ATOPIC DERMATITITIS.
MX2022015886A (en) Amidopyrimidone derivatives.
AR045156A1 (en) DERIVATIVES OF 5-INDOLILSULFONAMIDS, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS
AR007108A1 (en) ANTI-TUMOR AND ANTIVIRAL RENTAL AGENTS, PROCEDURE FOR THEIR PREPARATION, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH AGENTS.
DE60214401D1 (en) HETERO BICYCLIC CRF ANTAGONISTS
AR071721A1 (en) DERIVATIVES OF PIRIDIL-PROLINAMIDE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND ITS USE FOR THE TREATMENT OF ANXIETY, DEPRESSION AND DISORDERS OF THE SOUND.

Legal Events

Date Code Title Description
FB Suspension of granting procedure